These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21142449)

  • 1. Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment?
    Albayrak A; Uyanik MH; Cerrah S; Altas S; Dursun H; Demir M; Uslu H
    Viral Immunol; 2010 Dec; 23(6):633-8. PubMed ID: 21142449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
    Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
    J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?
    Inkaya AC; Demir NA; Kolgelier S; Sumer S; Demir LS; Ural O; Pehlivan FS; Aslan M; Arpaci A
    Medicine (Baltimore); 2017 Sep; 96(36):e7547. PubMed ID: 28885322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between serum levels of high mobility group box 1 and hepatitis B virus-related acute-on-chronic liver failure].
    Duan XZ; Hu JH; Li C; Liu FF; Liu XY; Tong JJ; Xin SJ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):434-7. PubMed ID: 24034844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between high mobility group box-1 protein and chronic hepatitis B infection with severe hepatitis B and acute-on-chronic liver failure: a meta-analysis.
    Hu YB; Hu DP; Fu RQ
    Minerva Med; 2017 Jun; 108(3):268-276. PubMed ID: 27973467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
    Dultz G; Gerber L; Farnik H; Berger A; Vermehren J; Pleli T; Zeuzem S; Piiper A; Kronenberger B; Waidmann O
    J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
    J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
    Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
    J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of P53 and high mobility group box 1 protein in different levels of liver fibrosis in chronic hepatitis B].
    Li L; Chen N; He L; Wen X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1217-22. PubMed ID: 26643425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered serum N-glycomics in chronic hepatitis B patients.
    Gui HL; Gao CF; Wang H; Liu XE; Xie Q; Dewaele S; Wang L; Zhuang H; Contreras R; Libert C; Chen C
    Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease.
    Alisi A; Nobili V; Ceccarelli S; Panera N; De Stefanis C; De Vito R; Vitali R; Bedogni G; Balsano C; Cucchiara S; Stronati L
    Expert Rev Mol Diagn; 2014 Jul; 14(6):763-71. PubMed ID: 24927058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B.
    Purnak T; Beyazit Y; Oztas E; Yesil Y; Efe C; Torun S; Celik T; Tenlik I; Kurt M; Ozaslan E
    J Renin Angiotensin Aldosterone Syst; 2012 Jun; 13(2):244-9. PubMed ID: 22277254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum level of HMGB1 in patients with hepatitis B and its clinical significance].
    Liu HB; Fan XG; Huang JJ; Li N; Peng JP; Li SL; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):812-5. PubMed ID: 18073062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?
    Ceylan B; Fincanci M; Yardimci C; Eren G; Tözalgan Ü; Müderrisoğlu C; Paşaoğlu E
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):606-12. PubMed ID: 23325286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group box-1 protein inhibits regulatory T cell immune activity in liver failure in patients with chronic hepatitis B.
    Wang LW; Chen H; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):499-507. PubMed ID: 20943459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
    Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
    J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.